HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru

INTRODUCTION: Transmitted, or any pretreatment drug resistance (TDR, PDR) can compromise efficacy of first‐line antiretroviral therapy (ART). In Peru, genotypic resistance testing is not routinely performed before ART initiation, and estimated PDR prevalence prior to 2012 ranged from 1.0% to 4.7%. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Trebelcock, William L, Lama, Javier R, Duerr, Ann, Sanchez, Hugo, Cabello, Robinson, Gilada, Trupti, Segura, Patricia, Reisner, Sari L, Mayer, Kenneth H, Mullins, James, Bender Ignacio, Rachel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880186/
https://www.ncbi.nlm.nih.gov/pubmed/31773888
http://dx.doi.org/10.1002/jia2.25411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880186/
https://www.ncbi.nlm.nih.gov/pubmed/31773888
http://dx.doi.org/10.1002/jia2.25411

Ejemplares similares